Skip to main content

Table 3 Effect of oral administration of cinnamaldehyde and costunolide on fasting blood glucose, insulin, HbA1c % and HOMA-IR in HFD fed rats for 30 days

From: Potential role of cinnamaldehyde and costunolide to counteract metabolic syndrome induced by excessive fructose consumption

Groups

Glucose

(mg/dl)

Insulin

mIU/mL)

HbA1c%

HOMA-IR

Control

85.33c ± 5.36

0.98b ± 0.09

3.43b ± 0.19

0.21c ± 0.03

HFD

167.00a ± 7.09

1.66a ± 0.11

5.70a ± 0.52

0.68a ± 0.04

HFD+ Cinnmaldehyde (40 mg/kg)

91.00c ± 3.21

1.56a ± 0.17

3.50b ± 0.10

0.34b ± 0.03

HFD+ Costunolide (20 mg/kg)

123.00b ± 8.71

1.34ab ± 0.19

4.23b ± 0.27

0.40b ± 0.03

HFD+ Metformin (300 mg/kg)

111.67b ± 5.54

1.37ab ± 0.12

3.63b ± 0 .34

0.34b ± 0 .04

  1. Values are means ± SE
  2. Means carrying different superscripts considered significant (P < 0.05)